Literature DB >> 15977202

Circulatory function and hepatorenal syndrome in cirrhosis.

Luis Ruiz-del-Arbol1, Alberto Monescillo, Carlos Arocena, Paz Valer, Pere Ginès, Víctor Moreira, José María Milicua, Wladimiro Jiménez, Vicente Arroyo.   

Abstract

The pathogenic mechanism of hepatorenal syndrome is not well established. We investigated the circulatory function in cirrhosis before and after the development of hepatorenal syndrome. Systemic and hepatic hemodynamics and the activity of endogenous vasoactive systems were measured in 66 patients who had cirrhosis with tense ascites and normal serum creatinine levels; measurements were repeated at follow-up in 27 cases in whom hepatorenal syndrome had developed. At baseline, mean arterial pressure and cardiac output were significantly higher, and hepatic venous pressure gradient, plasma renin activity, and norepinephrine concentration were significantly lower in patients who did not develop hepatorenal syndrome compared with those presenting with this complication. Peripheral vascular resistance was decreased to the same extent in the two groups. Plasma renin activity and cardiac output were the only independent predictors of hepatorenal syndrome. Hepatorenal syndrome occurred in the setting of a significant reduction in mean arterial pressure (83 +/- 9 to 75 +/- 7 mmHg; P < .001), cardiac output (6.0 +/- 1.2 to 5.4 +/- 1.5 L/min; P < .01), and wedged pulmonary pressure (9.2 +/- 2.6 to 7.5 +/- 2.6 mmHg; P < .001) and an increase in plasma renin activity (9.9 +/- 5.2 to 17.5 +/- 11.4 ng/mL . hr; P < .001), norepinephrine concentration (571 +/- 241 to 965 +/- 502 pg/mL; P < .001), and hepatic venous pressure gradient. No changes were observed in peripheral vascular resistance. In conclusion, these data indicate that hepatorenal syndrome is the result of a decrease in cardiac output in the setting of a severe arterial vasodilation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977202     DOI: 10.1002/hep.20766

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  107 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.

Authors:  Brian Erly; William D Carey; Baljendra Kapoor; J Mark McKinney; Mathew Tam; Weiping Wang
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

3.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

Review 4.  Treatment and management of ascites and hepatorenal syndrome: an update.

Authors:  Kurt Lenz; Robert Buder; Lisbeth Kapun; Martin Voglmayr
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

Review 5.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

Review 6.  Cardiovascular determinants of survival in cirrhosis.

Authors:  Samuel S Lee; Hongqun Liu
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

7.  Progress in treatment of massive ascites and hepatorenal syndrome.

Authors:  Alexander L Gerbes; Veit Gulberg
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

8.  Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?

Authors:  Waheed Abdelmonsef Mahmoud; Nadia Abdelaaty Abdelkader; Amal Mansor
Journal:  Indian J Gastroenterol       Date:  2013-11-29

9.  Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.

Authors:  Anna Licata; Marcello Maida; Ambra Bonaccorso; Fabio Salvatore Macaluso; Maria Cappello; Antonio Craxì; Piero Luigi Almasio
Journal:  World J Hepatol       Date:  2013-12-27

Review 10.  Renal dysfunction in cirrhosis.

Authors:  Nathalie H Urrunaga; Ayse L Mindikoglu; Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.